BTIS
BMRN icon

BB&T Investment Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

BB&T Investment Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$5K Buy
48
+1
+2% +$87 ﹤0.01% 1087
2017
Q3 		$5K Buy
47
+39
+488% +$3.45K ﹤0.01% 935
2017
Q2 		$1K Hold
8
– – ﹤0.01% 1018
2017
Q1 		$1K Buy
+8
New +$712 ﹤0.01% 970

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB&T Investment Services's BMRN Position: Q4 2017 in Review

BB&T Investment Services increased its BioMarin Pharmaceuticals (BMRN) stake by 2.1% in Q4 2017, buying an estimated $87 and bringing the position to 48 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

BB&T Investment Services first reported a position in BMRN in Q1 2017 and has held it in 4 quarters since. 438 funds tracked by Wall St. Rank hold BMRN as of Q4 2017.

  • BB&T Investment Services held 48 shares of BioMarin Pharmaceuticals worth $5K as of Q4 2017.
  • BB&T Investment Services bought 1 BioMarin Pharmaceuticals share in Q4 2017, an estimated $87.
  • BioMarin Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1087 holding.
  • BB&T Investment Services first reported a position in BioMarin Pharmaceuticals in Q1 2017 and has held it in 4 quarters since.
  • 438 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.